The Food and Drug Administration approved Gilead's twice-yearly antiviral drug for preventing HIV. The company and some experts say it is a milestone that could help bring the world closer to ending ...

South Africa will launch Lenacapavir, a six-month HIV prevention injection, in six provinces, targeting all HIV-negative individuals to curb new infections.

Fighting against an illness with no treatment and institutional racism, Black queer communities had to look inward for support.

The United States says it will support access to a new twice-yearly HIV prevention injection for 271,000 people in Zimbabwe over the next three years, as part of efforts to curb new infections and ...